Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-26-083680
Filing Date
2026-07-15
Accepted
2026-07-15 06:05:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 tm2615250-5_424b4.htm 424B4 394070
2 GRAPHIC lg_aeonbiopharma-4c.jpg GRAPHIC 24940
  Complete submission text file 0001104659-26-083680.txt   429673
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-297327 | Film No.: 261175793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)